BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2382730)

  • 1. Enhancement of tumor necrosis factor-induced endothelial cell injury by cycloheximide.
    Nolop KB; Ryan US
    Am J Physiol; 1990 Aug; 259(2 Pt 1):L123-9. PubMed ID: 2382730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis.
    Polunovsky VA; Wendt CH; Ingbar DH; Peterson MS; Bitterman PB
    Exp Cell Res; 1994 Oct; 214(2):584-94. PubMed ID: 7925652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cells.
    Nio Y; Zighelboim J; Berek J; Bonavida B
    Cancer Chemother Pharmacol; 1990; 26(1):1-8. PubMed ID: 2322985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-alpha induces endothelial cell F-actin depolymerization, new actin synthesis, and barrier dysfunction.
    Goldblum SE; Ding X; Campbell-Washington J
    Am J Physiol; 1993 Apr; 264(4 Pt 1):C894-905. PubMed ID: 8476021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/cycloheximide-induced cerebral endothelial cell death.
    Xu J; Yeh CH; Chen S; He L; Sensi SL; Canzoniero LM; Choi DW; Hsu CY
    J Biol Chem; 1998 Jun; 273(26):16521-6. PubMed ID: 9632721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha augments pulmonary arterial transendothelial albumin flux in vitro.
    Goldblum SE; Sun WL
    Am J Physiol; 1990 Feb; 258(2 Pt 1):L57-67. PubMed ID: 1689552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human endothelial cell response to lipopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis.
    Pohlman TH; Harlan JM
    Cell Immunol; 1989 Mar; 119(1):41-52. PubMed ID: 2784080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor enhances the neutrophil-dependent increase in endothelial permeability.
    Gibbs LS; Lai L; Malik AB
    J Cell Physiol; 1990 Dec; 145(3):496-500. PubMed ID: 1980275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation and injury of endothelial cells by cytokines.
    Pober JS
    Pathol Biol (Paris); 1998 Mar; 46(3):159-63. PubMed ID: 9769910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells.
    Estrada C; Gómez C; Martín C; Moncada S; González C
    Biochem Biophys Res Commun; 1992 Jul; 186(1):475-82. PubMed ID: 1378728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha.
    Bussolino F; Camussi G; Baglioni C
    J Biol Chem; 1988 Aug; 263(24):11856-61. PubMed ID: 3261295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A possible involvement of ion transporter in tumor necrosis factor alpha and cycloheximide-induced apoptosis of endothelial cells.
    Fujita H; Morita I; Murota S
    Mediators Inflamm; 1999; 8(4-5):211-8. PubMed ID: 10704075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability.
    Royall JA; Berkow RL; Beckman JS; Cunningham MK; Matalon S; Freeman BA
    Am J Physiol; 1989 Dec; 257(6 Pt 1):L399-410. PubMed ID: 2610269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectodomain shedding of TNF receptor 1 induced by protein synthesis inhibitors regulates TNF-alpha-mediated activation of NF-kappaB and caspase-8.
    Ogura H; Tsukumo Y; Sugimoto H; Igarashi M; Nagai K; Kataoka T
    Exp Cell Res; 2008 Apr; 314(6):1406-14. PubMed ID: 18289527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor enhances endothelial cell susceptibility to oxygen toxicity: role of glutathione.
    Marcho Z; White JE; Higgins PJ; Tsan MF
    Am J Respir Cell Mol Biol; 1991 Dec; 5(6):556-62. PubMed ID: 1958383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.
    van de Kar NC; Monnens LA; Karmali MA; van Hinsbergh VW
    Blood; 1992 Dec; 80(11):2755-64. PubMed ID: 1333300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic cell death kinetics in vitro depend on the cell types and the inducers used.
    Wolbers F; Buijtenhuijs P; Haanen C; Vermes I
    Apoptosis; 2004 May; 9(3):385-92. PubMed ID: 15258471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cycloheximide-mediated sensitization to TNF-alpha-induced apoptosis in human colorectal cancer cell line COLO 205; role of FLIP and metabolic inhibitors.
    Pajak B; Gajkowska B; Orzechowski A
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():101-18. PubMed ID: 16077198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of tumor necrosis factor-alpha for human umbilical vein endothelial cells.
    Schuger L; Varani J; Marks RM; Kunkel SL; Johnson KJ; Ward PA
    Lab Invest; 1989 Jul; 61(1):62-8. PubMed ID: 2747218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that tumor necrosis factor triggers apoptosis in human endothelial cells by interleukin-1-converting enzyme-like protease-dependent and -independent pathways.
    Slowik MR; Min W; Ardito T; Karsan A; Kashgarian M; Pober JS
    Lab Invest; 1997 Sep; 77(3):257-67. PubMed ID: 9314949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.